Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.97
(
1.04%
)
US TECH 100
26,685.20
(
0.84%
)
Dow Jones
49,695.49
(
1.71%
)
Brent Oil
110.07
(
-2.06%
)
Bitcoin
76,407.56
(
0.83%
)
News Focus
News Focus
Post# of 257472
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 50
Posts 5533
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: jbog post# 250550

Wednesday, 02/07/2024 11:23:19 PM

Wednesday, February 07, 2024 11:23:19 PM

Post# of 257472
oral remdesivir update from yesterday:

Announced that the Phase 3 OAKTREE trial of obeldesivir in non-hospitalized participants without risk factors for developing severe COVID-19 did not meet its primary endpoint of improvement in time to symptom alleviation.



https://www.gilead.com/news-and-press/press-room/press-releases/2024/2/gilead-sciences-announces-fourth-quarter-and-full-year-2023-financial-results
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now